Drug Trial Radar · NCT00094302
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Last checked: Nov 19, 2026Latest source record: Mar 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,445
Actual
Start
Aug 2006
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Carelon ResearchAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- First posted
- Oct 15, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
Conditions
- Cardiovascular Diseases
- Heart Diseases
- Heart Failure, Congestive
Interventions
SpironolactoneDrug
Spironolactone (an aldosterone antagonist) is supplied as 15 mg tablets. Drug is taken orally by subjects. The initial study drug dose is 15 mg/day (one tablet) and may be titrated up to 30 mg/day (two tablets) or 45 mg/day (three tablets). Subjects are on study drug for the duration of the trial.
PlaceboDrug
Placebo of spironolactone
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Outcome of Cardiovascular Mortality, Aborted Cardiac Arrest, or Hospitalization for the Management of Heart Failure, Whichever Occurred FirstTime frame: Randomization through each subject's last semi-annual visit, up to a maximum of 6 years per subject.
Locations
270 sites in 6 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Cardiovascular Consultants, Ltd.
Glendale, Arizona
Carl T. Hayden VA Medical Center
Phoenix, Arizona
Central Arkansas Veterans Healthcare System
Little Rock, Arkansas
Heart Clinic Arkansas
Little Rock, Arkansas
Cynthia Thaik
Burbank, California
Fresno VA Medical Center
Fresno, California
Clinica Medica San Miguel
Los Angeles, California
CAPRI
Los Angeles, California
VA Medical Center West Los Angeles
Los Angeles, California
Mehrdad Kevin Ariani, MD, Inc.
Northridge, California
UC Davis Medical Center
Sacremento, California
Central Coast Cardiology
Salinas, California
Naval Medical Center San Diego
San Diego, California
Olive View - UCLA Medial Center
Sylmar, California
University of Colorado Health Sciences Center
Aurora, Colorado
Cardio-Vascular Institute
Greeley, Colorado
University of Connecticut Health Center
Farmington, Connecticut
Washington Hospital Center
Washington D.C., District of Columbia
Howard University Hospital
Washington D.C., District of Columbia
Washington DC VA Hospital
Washington D.C., District of Columbia
Daytona Heart Group
Daytona Beach, Florida
M & O Clinical Research, LLC
Fort Lauderdale, Florida
Florida Heart Center
Ft. Pierce, Florida
University of Florida
Gainesville, Florida
Mayo Clinic Florida
Jacksonville, Florida
Brevard Cardiovascular Research Associates, Inc
Rockledge, Florida
Tallahassee Research Institute
Tallahassee, Florida
Emory University at Grady Health System
Atlanta, Georgia
Morehouse School of Medicine
Atlanta, Georgia
Northside Cardiology Center
Atlanta, Georgia
InnovaMed Alliance
Marietta, Georgia
Rush University Medical Center
Chicago, Illinois
University of Illinois at Chicago Medical Center
Chicago, Illinois
Northwestern University
Chicago, Illinois
Cardiovascular Research Foundation
Elk Grove Village, Illinois
Heart, Lung and Vascular Institute
Peoria, Illinois
HeartCare Midwest
Peoria, Illinois
The Care Group, LLC
Indianapolis, Indiana
Cardiovascular Research of Northwest Indiana, LLC
Munster, Indiana
Showing 40 of 270 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.